The SPRINT trial suggested a more aggressive blood pressure-lowering target reduced the rate of cardiovascular events in hypertensive people, but a new secondary analysis of the trial indicates such an approach may actually be harmful for smokers.

A smartphone’s camera and flashlight features can detect changes in blood flow and identify type 2 diabetes with accuracy comparable to traditional, clinic-based risk scores, new research suggests.

In its first scientific statement on accurately measuring blood pressure in 14 years, the American Heart Association gave a stronger recommendation for oscillometric devices and updated the evidence surrounding ambulatory and home blood pressure monitoring techniques.

Three-quarters of patients who are diabetic and undergo Roux-en-Y gastric bypass surgery experience remission of the disease within a year of their procedure, Reuters reported of a Danish study March 1.

A literature review out of West Virginia University suggests diabetics or those at risk for diabetes and metabolic syndrome could lower that risk by sticking to a largely plant-based diet.

An ongoing FDA investigation of generic angiotensin II receptor blocker (ARB) drugs used to treat hypertension and heart failure found higher-than-acceptable levels of the carcinogen N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) in recent batches of losartan potassium tablets, prompting a voluntary recall of 87 lots, the agency announced March 1. NMBA is the third different carcinogenic impurity recently discovered in ARBs.

Women with type 2 diabetes are more likely than those without to develop more advanced, aggressive forms of breast cancer, Reuters reported of a study Feb. 27.

A recently published mouse study may offer clues about why premenopausal women are less prone than men to “nondipping hypertension,” a condition in which blood pressure doesn’t drop its normal 10 to 20 percent at night.